THE RENAL BENEFITS OF SODIUM GLUCOSE CO-TRANSPORTER 2 INHIBITORS MUST BE ASSESSED BASED ON A STANDARDISED DEFINITION OF RENAL COMPOSITE OUTCOMES: A META-ANALYSIS
Back
Abstract Number
WCN23-0041
Categories
Chronic Kidney Disease, Hypertension, Diabetes and CVD
Topic - Chronic Kidney Disease, Hypertension, Diabetes and CVD
Diabetic Kidney Disease, Drugs and Treatments
Topic - AKI, Electrolytes, Acid-base Disorders, Tropical Diseases, RPGN and Pregnancy
Topic - Kidney Failure (Former ESKD), incl. Dialysis, Transplantation, Conservative Care
Topic - Special Covid-19
Topic - Education
Abstract Title
THE RENAL BENEFITS OF SODIUM GLUCOSE CO-TRANSPORTER 2 INHIBITORS MUST BE ASSESSED BASED ON A STANDARDISED DEFINITION OF RENAL COMPOSITE OUTCOMES: A META-ANALYSIS
Co-authors
Ghosal, S.(1)*;Sinha, B.(2);
ie:
Azwin Z.1, Siti Y.1, John D.2
Institution
(1)Nightingale Hospital, Endocrinology, Kolkata, India;(2)Amri Hospitals, Endocrinology, Kolkata, India;
E-Poster
https://storage.unitedwebnetwork.com/files/1041/be6127fc315dd5fb9189e8f9e393877f.pdf
Audio File
if any